Bristol: A cancer drug could be used to treat patients suffering from heart attacks in the future, a study has suggested.
Experiments on mice at the University of Bristol in the UK have revealed that daily vaccinations can help prevent irreversible damage to the heart after a heart attack.
Medicines called MEK inhibitors also promote the growth of new healthy blood vessels that are usually damaged in acute heart attacks. Apart from this, the heart muscles are also affected in a heart attack.
Patients who have a heart attack, usually due to blocked arteries, experience cardiac arrest as the lack of blood flow damages parts of the heart.
It is hoped that giving the drug shortly after a stroke can maintain healthy blood flow and keep the heart healthy.